Molecular Regulation of Inducible Nitric Oxide Synthase

Nitric Oxide

Volumn , Issue , 2010, Pages 269-300

  Du, Qiang ^a   Geller, David A ^a  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84882524634     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-0-12-373866-0.00008-3     Document Type: Chapter

References (200)

1. Ahn K.S., Aggarwal B.B. Transcription factor NF-kappaB: a sensor for smoke and stress signals. Ann. N. Y. Acad. Sci. 2005, 1056:218-233.
2. Alley E.W., Murphy W.J., Russell S.W. A classical enhancer element responsive to both lipopolysaccharide and interferon-gamma augments induction of the iNOS gene in mouse macrophages. Gene 1995, 158:247-251.
3. Ambs S., Hussain S.P., Harris C.C. Interactive effects of nitric oxide and the p53 tumor suppressor gene in carcinogenesis and tumor progression. FASEB J. 1997, 11:443-448.
4. Ambs S., Ogunfusika M.O., Merriam W.G., Bennett W.P., Billiar T.R., Harris C.C. Up-regulation of inducible nitric oxide synthase expression in cancer-prone p53 knockout mice. Proc. Natl Acad. Sci. U. S. A 1998, 95:8823-8828.
5. Arany I., Brysk M.M., Brysk H., Tyring S.K. Regulation of inducible nitric oxide synthase mRNA levels by differentiation and cytokines in human keratinocytes. Biochem. Biophys. Res. Commun. 1996, 220:618-622.
6. Bae I.K., Min H.Y., Han A.R., Seo E.K., Lee S.K. Suppression of lipopolysaccharide-induced expression of inducible nitric oxide synthase by brazilin in RAW 264.7 macrophage cells. Eur. J. Pharmacol. 2005, 513:237-242.
7. Bandino A., Compagnone A., Bravoco V., Cravanzola C., Lomartire A., Rossetto C., Novo E., Cannito S., Valfre di B.L., Zamara E., Autelli R., Parola M., Colombatto S. Beta-catenin triggers nuclear factor kappaB-dependent up-regulation of hepatocyte inducible nitric oxide synthase. Int. J. Biochem. Cell Biol. 2008, 40:1861-1871.
8. Berkman N., Robichaud A., Robbins R.A., Roesems G., Haddad E.B., Barnes P.J., Chung K.F. Inhibition of inducible nitric oxide synthase expression by interleukin-4 and interleukin-13 in human lung epithelial cells. Immunology 1996, 89:363-367.
9. Bernardo A., Levi G., Minghetti L. Role of the peroxisome proliferator-activated receptor-gamma (PPAR-gamma) and its natural ligand 15-deoxy-Delta12, 14-prostaglandin J2 in the regulation of microglial functions. Eur. J. Neurosci. 2000, 12:2215-2223.
10. Bertholet S., Tzeng E., Felley-Bosco E., Mauel J. Expression of the inducible NO synthase in human monocytic U937 cells allows high output nitric oxide production. J. Leukoc. Biol. 1999, 65:50-58.
11. Blanchette J., Dayyeh I.A., Hassani K., Whitcombe L., Olivier M. Regulation of macrophage nitric oxide production by the protein tyrosine phosphatase Src homology 2 domain phosphotyrosine phosphatase 1 (SHP-1). Immunology 2009, 127:123-133.
12. Blanchette J., Jaramillo M., Olivier M. Signalling events involved in interferon-gamma-inducible macrophage nitric oxide generation. Immunology 2003, 108:513-522.
13. Bredt D.S., Hwang P.M., Glatt C.E., Lowenstein C., Reed R.R., Snyder S.H. Cloned and expressed nitric oxide synthase structurally resembles cytochrome P-450 reductase. Nature 1991, 351:714-718.
14. Caput D., Beutler B., Hartog K., Thayer R., Brown-Shimer S., Cerami A. Identification of a common nucleotide sequence in the 3'-untranslated region of mRNA molecules specifying inflammatory mediators. Proc. Natl Acad. Sci. U. S. A 1986, 83:1670-1674.
15. Chan G.C., Fish J.E., Mawji I.A., Leung D.D., Rachlis A.C., Marsden P.A. Epigenetic basis for the transcriptional hyporesponsiveness of the human inducible nitric oxide synthase gene in vascular endothelial cells. J. Immunol. 2005, 175:3846-3861.
16. Chan J.Y., Ou C.C., Wang L.L., Chan S.H. Heat shock protein 70 confers cardiovascular protection during endotoxemia via inhibition of nuclear factor-kappaB activation and inducible nitric oxide synthase expression in the rostral ventrolateral medulla. Circulation 2004, 110:3560-3566.
17. Charles I.G., Palmer R.M., Hickery M.S., Bayliss M.T., Chubb A.P., Hall V.S., Moss D.W., Moncada S. Cloning, characterization, and expression of a cDNA encoding an inducible nitric oxide synthase from the human chondrocyte. Proc. Natl Acad. Sci. U. S. A 1993, 90:11419-11423.
18. Chartrain N.A., Geller D.A., Koty P.P., Sitrin N.F., Nussler A.K., Hoffman E.P., Billiar T.R., Hutchinson N.I., Mudgett J.S. Molecular cloning, structure, and chromosomal localization of the human inducible nitric oxide synthase gene. J. Biol. Chem. 1994, 269:6765-6772.
19. Chen C.W., Chang Y.H., Tsi C.J., Lin W.W. Inhibition of IFN-gamma-mediated inducible nitric oxide synthase induction by the peroxisome proliferator-activated receptor gamma agonist, 15-deoxy-delta 12,14-prostaglandin J2, involves inhibition of the upstream Janus kinase/STAT1 signaling pathway. J. Immunol. 2003, 171:979-988.
20. Chio C.C., Chang Y.H., Hsu Y.W., Chi K.H., Lin W.W. PKA-dependent activation of PKC, p38 MAPK and IKK in macrophage: implication in the induction of inducible nitric oxide synthase and interleukin-6 by dibutyryl cAMP. Cell Signal 2004, 16:565-575.
21. Chittezhath M., Deep G., Singh R.P., Agarwal C., Agarwal R. Silibinin inhibits cytokine-induced signaling cascades and down-regulates inducible nitric oxide synthase in human lung carcinoma A549 cells. Mol. Cancer Ther. 2008, 7:1817-1826.
22. Chu S.C., Wu H.P., Banks T.C., Eissa N.T., Moss J. Structural diversity in the 5'-untranslated region of cytokine-stimulated human inducible nitric oxide synthase mRNA. J. Biol. Chem. 1995, 270:10625-10630.
23. Clerc R.G., Corcoran L.M., LeBowitz J.H., Baltimore D., Sharp P.A. The B-cell-specific Oct-2 protein contains POU box- and homeo box-type domains. Genes Dev. 1988, 2:1570-1581.
24. Coccia E.M., Stellacci E., Marziali G., Weiss G., Battistini A. IFN-gamma and IL-4 differently regulate inducible NO synthase gene expression through IRF-1 modulation. Int. Immunol. 2000, 12:977-985.
25. Colasanti M., Persichini T., Menegazzi M., Mariotto S., Giordano E., Caldarera C.M., Sogos V., Lauro G.M., Suzuki H. Induction of nitric oxide synthase mRNA expression. Suppression by exogenous nitric oxide. J. Biol. Chem. 1995, 270:26731-26733.
26. Da S.J., Pierrat B., Mary J.L., Lesslauer W. Blockade of p38 mitogen-activated protein kinase pathway inhibits inducible nitric-oxide synthase expression in mouse astrocytes. J. Biol. Chem. 1997, 272:28373-28380.
27. Darville M.I., Terryn S., Eizirik D.L. An octamer motif is required for activation of the inducible nitric oxide synthase promoter in pancreatic beta-cells. Endocrinology 2004, 145:1130-1136.
28. Dash P.R., Whitley G.S., Ayling L.J., Johnstone A.P., Cartwright J.E. Trophoblast apoptosis is inhibited by hepatocyte growth factor through the Akt and beta-catenin mediated up-regulation of inducible nitric oxide synthase. Cell Signal. 2005, 17:571-580.
29. Dawn B., Xuan Y.T., Guo Y., Rezazadeh A., Stein A.B., Hunt G., Wu W.J., Tan W., Bolli R. IL-6 plays an obligatory role in late preconditioning via JAK-STAT signaling and upregulation of iNOS and COX-2. Cardiovasc. Res. 2004, 64:61-71.
30. de Vera M.E., Shapiro R.A., Nussler A.K., Mudgett J.S., Simmons R.L., Morris S.M., Billiar T.R., Geller D.A. Transcriptional regulation of human inducible nitric oxide synthase (NOS2) gene by cytokines: initial analysis of the human NOS2 promoter. Proc. Natl Acad. Sci. U. S. A 1996, 93:1054-1059.
31. de Vera M.E., Taylor B.S., Wang Q., Shapiro R.A., Billiar T.R., Geller D.A. Dexamethasone suppresses iNOS gene expression by upregulating I-kappa B alpha and inhibiting NF-kappa B. Am. J. Physiol. 1997, 273:G1290-G1296.
32. de Vera M.E., Wong J.M., Zhou J.Y., Tzeng E., Wong H.R., Billiar T.R., Geller D.A. Cytokine-induced nitric oxide synthase gene transcription is blocked by the heat shock response in human liver cells. Surgery 1996, 120:144-149.
33. De S.D., Maiuri M.C., Iovine B., Ialenti A., Bevilacqua M.A., Carnuccio R. The role of NF-kappaB, IRF-1, and STAT-1alpha transcription factors in the iNOS gene induction by gliadin and IFN-gamma in RAW 264.7 macrophages. J. Mol. Med. 2006, 84:65-74.
34. Dell'Albani P., Santangelo R., Torrisi L., Nicoletti V.G., de V.J., Giuffrida Stella A.M. JAK/STAT signaling pathway mediates cytokine-induced iNOS expression in primary astroglial cell cultures. J. Neurosci. Res. 2001, 65:417-424.
35. Deng W.G., Wu K.K. Regulation of inducible nitric oxide synthase expression by p300 and p50 acetylation. J. Immunol. 2003, 171:6581-6588.
36. Ding A., Nathan C.F., Graycar J., Derynck R., Stuehr D.J., Srimal S. Macrophage deactivating factor and transforming growth factors-beta 1 -beta 2 and -beta 3 inhibit induction of macrophage nitrogen oxide synthesis by IFN-gamma. J. Immunol. 1990, 145:940-944.
37. Du Q., Park K.S., Guo Z., He P., Nagashima M., Shao L., Sahai R., Geller D.A., Hussain S.P. Regulation of human nitric oxide synthase 2 expression by Wnt beta-catenin signaling. Cancer Res. 2006, 66:7024-7031.
38. Eberhardt W., Pluss C., Hummel R., Pfeilschifter J. Molecular mechanisms of inducible nitric oxide synthase gene expression by IL-1beta and cAMP in rat mesangial cells. J. Immunol. 1998, 160:4961-4969.
39. Eissa N.T., Strauss A.J., Haggerty C.M., Choo E.K., Chu S.C., Moss J. Alternative splicing of human inducible nitric-oxide synthase mRNA. tissue-specific regulation and induction by cytokines. J. Biol. Chem. 1996, 271:27184-27187.
40. Eissa N.T., Yuan J.W., Haggerty C.M., Choo E.K., Palmer C.D., Moss J. Cloning and characterization of human inducible nitric oxide synthase splice variants: a domain, encoded by exons 8 and 9, is critical for dimerization. Proc. Natl Acad. Sci. U. S. A 1998, 95:7625-7630.
41. Erwin P.A., Mitchell D.A., Sartoretto J., Marletta M.A., Michel T. Subcellular targeting and differential S-nitrosylation of endothelial nitric-oxide synthase. J. Biol. Chem. 2006, 281:151-157.
42. Farivar R.S., Brecher P. Salicylate is a transcriptional inhibitor of the inducible nitric oxide synthase in cultured cardiac fibroblasts. J. Biol. Chem. 1996, 271:31585-31592.
43. Farmer G., Friedlander P., Colgan J., Manley J.L., Prives C. Transcriptional repression by p53 involves molecular interactions distinct from those with the TATA box binding protein. Nucleic Acids Res. 1996, 24:4281-4288.
44. Fechir M., Linker K., Pautz A., Hubrich T., Forstermann U., Rodriguez-Pascual F., Kleinert H. Tristetraprolin regulates the expression of the human inducible nitric-oxide synthase gene. Mol. Pharmacol. 2005, 67:2148-2161.
45. Fechir M., Linker K., Pautz A., Hubrich T., Kleinert H. The RNA binding protein TIAR is involved in the regulation of human iNOS expression. Cell Mol. Biol. (Noisy. -le-grand) 2005, 51:299-305.
46. Feinstein D.L., Galea E., Aquino D.A., Li G.C., Xu H., Reis D.J. Heat shock protein 70 suppresses astroglial-inducible nitric-oxide synthase expression by decreasing NFkappaB activation. J. Biol. Chem. 1996, 271:17724-17732.
47. Feng X., Guo Z., Nourbakhsh M., Hauser H., Ganster R., Shao L., Geller D.A. Identification of a negative response element in the human inducible nitric-oxide synthase (hiNOS) promoter: The role of NF-kappa B-repressing factor (NRF) in basal repression of the hiNOS gene. Proc. Natl Acad. Sci. U. S. A 2002, 99:14212-14217.
48. Forrester K., Ambs S., Lupold S.E., Kapust R.B., Spillare E.A., Weinberg W.C., Felley-Bosco E., Wang X.W., Geller D.A., Tzeng E., Billiar T.R., Harris C.C. Nitric oxide-induced p53 accumulation and regulation of inducible nitric oxide synthase expression by wild-type p53. Proc. Natl Acad. Sci. U. S. A 1996, 93:2442-2447.
49. Fujimura M., Tominaga T., Kato I., Takasawa S., Kawase M., Taniguchi T., Okamoto H., Yoshimoto T. Attenuation of nitric oxide synthase induction in IRF-1-deficient glial cells. Brain Res. 1997, 759:247-250.
50. Galea E., Feinstein D.L. Regulation of the expression of the inflammatory nitric oxide synthase (NOS2) by cyclic AMP. FASEB J. 1999, 13:2125-2137.
51. Ganster R.W., Geller D.A. Molecular regulation of inducible nitric oxide synthase. Nitric Oxide 2000, 129-156. Academic Press, San Diego. L. Ignarro (Ed.).
52. Ganster R.W., Guo Z., Shao L., Geller D.A. Differential effects of TNF-alpha and IFN-gamma on gene transcription mediated by NF-kappaB-Stat1 interactions. J. Interferon Cytokine Res. 2005, 25:707-719.
53. Ganster R.W., Taylor B.S., Shao L., Geller D.A. Complex regulation of human inducible nitric oxide synthase gene transcription by Stat 1 and NF-kappa B. Proc. Natl Acad. Sci. U. S. A 2001, 98:8638-8643.
54. Gao J., Morrison D.C., Parmely T.J., Russell S.W., Murphy W.J. An interferon-gamma-activated site (GAS) is necessary for full expression of the mouse iNOS gene in response to interferon-gamma and lipopolysaccharide. J. Biol. Chem. 1997, 272:1226-1230.
55. Gao J.J., Filla M.B., Fultz M.J., Vogel S.N., Russell S.W., Murphy W.J. Autocrine/ paracrine IFN-alphabeta mediates the lipopolysaccharide-induced activation of transcription factor Stat1alpha in mouse macrophages: pivotal role of Stat1alpha in induction of the inducible nitric oxide synthase gene. J. Immunol. 1998, 161:4803-4810.
56. Gay R.D., Dawson S.J., Murphy W.J., Russell S.W., Latchman D.S. Activation of the iNOS gene promoter by Brn-3 POU family transcription factors is dependent upon the octamer motif in the promoter. Biochim. Biophys. Acta. 1998, 1443:315-322.
57. Geller D.A., de Vera M.E., Russell D.A., Shapiro R.A., Nussler A.K., Simmons R.L., Billiar T.R. A central role for IL-1 beta in the in vitro and in vivo regulation of hepatic inducible nitric oxide synthase. IL-1 beta induces hepatic nitric oxide synthesis. J. Immunol. 1995, 155:4890-4898.
58. Geller D.A., Lowenstein C.J., Shapiro R.A., Nussler A.K., Di S.M., Wang S.C., Nakayama D.K., Simmons R.L., Snyder S.H., Billiar T.R. Molecular cloning and expression of inducible nitric oxide synthase from human hepatocytes. Proc. Natl Acad. Sci. U. S. A 1993, 90:3491-3495.
59. Geller D.A., Nussler A.K., Di S.M., Lowenstein C.J., Shapiro R.A., Wang S.C., Simmons R.L., Billiar T.R. Cytokines, endotoxin, and glucocorticoids regulate the expression of inducible nitric oxide synthase in hepatocytes. Proc. Natl Acad. Sci. U. S. A 1993, 90:522-526.
60. Gilad E., Wong H.R., Zingarelli B., Virag L., O'Connor M., Salzman A.L., Szabo C. Melatonin inhibits expression of the inducible isoform of nitric oxide synthase in murine macrophages: role of inhibition of NFkappaB activation. FASEB J. 1998, 12:685-693.
61. Gilbert R.S., Herschman H.R. Transforming growth factor beta differentially modulates the inducible nitric oxide synthase gene in distinct cell types. Biochem. Biophys. Res. Commun. 1993, 195:380-384.
62. Goldring C.E., Reveneau S., Pinard D., Jeannin J.F. Hyporesponsiveness to lipopolysaccharide alters the composition of NF-kappaB binding to the regulatory regions of inducible nitric oxide synthase gene. Eur. J. Immunol. 1998, 28:2960-2970.
63. Grigoriadis G., Zhan Y., Grumont R.J., Metcalf D., Handman E., Cheers C., Gerondakis S. The Rel subunit of NF-kappaB-like transcription factors is a positive and negative regulator of macrophage gene expression: distinct roles for Rel in different macrophage populations. EMBO J. 1996, 15:7099-7107.
64. Griscavage J.M., Rogers N.E., Sherman M.P., Ignarro L.J. Inducible nitric oxide synthase from a rat alveolar macrophage cell line is inhibited by nitric oxide. J. Immunol. 1993, 151:6329-6337.
65. Guo F.H., Comhair S.A., Zheng S., Dweik R.A., Eissa N.T., Thomassen M.J., Calhoun W., Erzurum S.C. Molecular mechanisms of increased nitric oxide (NO) in asthma: evidence for transcriptional and post-translational regulation of NO synthesis. J. Immunol. 2000, 164:5970-5980.
66. Guo F.H., De Raeve H.R., Rice T.W., Stuehr D.J., Thunnissen F.B., Erzurum S.C. Continuous nitric oxide synthesis by inducible nitric oxide synthase in normal human airway epithelium in vivo. Proc. Natl Acad. Sci. U. S. A 1995, 92:7809-7813.
67. Guo Z., Shao L., Du Q., Park K.S., Geller D.A. Identification of a classic cytokine-induced enhancer upstream in the human iNOS promoter. FASEB J. 2007, 21:535-542.
68. Guo Z., Shao L., Feng X., Reid K., Marderstein E., Nakao A., Geller D.A. A critical role for C/EBPbeta binding to the AABS promoter response element in the human iNOS gene. FASEB J. 2003, 17:1718-1720.
69. Gupta A.K., Kone B.C. CCAAT/enhancer binding protein-beta trans-activates murine nitric oxide synthase 2 gene in an MTAL cell line. Am. J. Physiol. 1999, 276:F599-F605.
70. Hamalainen M., Korhonen R., Moilanen E. Calcineurin inhibitors down-regulate iNOS expression by destabilising mRNA. Int. Immunopharmacol. 2009, 9:159-167.
71. Herr W., Sturm R.A., Clerc R.G., Corcoran L.M., Baltimore D., Sharp P.A., Ingraham H.A., Rosenfeld M.G., Finney M., Ruvkun G. The POU domain: a large conserved region in the mammalian pit-1, oct-1, oct-2, and Caenorhabditis elegans unc-86 gene products. Genes Dev 1988, 2:1513-1516.
72. Hibbs J.B., Westenfelder C., Taintor R., Vavrin Z., Kablitz C., Baranowski R.L., Ward J.H., Menlove R.L., McMurry M.P., Kushner J.P. Evidence for cytokine-inducible nitric oxide synthesis from L-arginine in patients receiving interleukin-2 therapy. J. Clin. Invest. 1992, 89:867-877.
73. Hirafuji M., Tsunoda M., Machida T., Hamaue N., Endo T., Miyamoto A., Minami M. Reduced expressions of inducible nitric oxide synthase and cyclooxygenase-2 in vascular smooth muscle cells of stroke-prone spontaneously hypertensive rats. Life Sci. 2002, 70:917-926.
74. Hua L.L., Zhao M.L., Cosenza M., Kim M.O., Huang H., Tanowitz H.B., Brosnan C.F., Lee S.C. Role of mitogen-activated protein kinases in inducible nitric oxide synthase and TNFalpha expression in human fetal astrocytes. J. Neuroimmunol. 2002, 126:180-189.
75. Ignarro L.J., Buga G.M., Wood K.S., Byrns R.E., Chaudhuri G. Endothelium-derived relaxing factor produced and released from artery and vein is nitric oxide. Proc. Natl. Acad. Sci. U. S. A 1987, 84:9265-9269.
76. Imai T., Hirata Y., Kanno K., Marumo F. Induction of nitric oxide synthase by cyclic AMP in rat vascular smooth muscle cells. J. Clin. Invest. 1994, 93:543-549.
77. Jeohn G.H., Chang R.C., Kim W.G., Wilson B., Mohney R.P., Wetsel W.C., Hong J.S. Post-transcriptional inhibition of lipopolysaccharide-induced expression of inducible nitric oxide synthase by Go6976 in murine microglia. Brain Res. Mol. Brain Res. 2000, 79:18-31.
78. Jobin C., Panja A., Hellerbrand C., Iimuro Y., Didonato J., Brenner D.A., Sartor R.B. Inhibition of proinflammatory molecule production by adenovirus-mediated expression of a nuclear factor kappaB super-repressor in human intestinal epithelial cells. J. Immunol. 1998, 160:410-418.
79. Kamijo R., Shapiro D., Le J., Huang S., Aguet M., Vilcek J. Generation of nitric oxide and induction of major histocompatibility complex class II antigen in macrophages from mice lacking the interferon gamma receptor. Proc. Natl Acad. Sci. U. S. A 1993, 90:6626-6630.
80. Kelleher Z.T., Matsumoto A., Stamler J.S., Marshall H.E. NOS2 regulation of NF-kappaB by S-nitrosylation of p65. J. Biol. Chem. 2007, 282:30667-30672.
81. Kiemer A.K., Vollmar A.M. Autocrine regulation of inducible nitric-oxide synthase in macrophages by atrial natriuretic peptide. J. Biol. Chem. 1998, 273:13444-13451.
82. Kim T.K., Maniatis T. The mechanism of transcriptional synergy of an in vitro assembled interferon-beta enhanceosome. Mol. Cell 1997, 1:119-129.
83. Kishimoto J., Spurr N., Liao M., Lizhi L., Emson P., Xu W. Localization of brain nitric oxide synthase (NOS) to human chromosome 12. Genomics 1992, 14:802-804.
84. Kleinert H., Euchenhofer C., Fritz G., Ihrig-Biedert I., Forstermann U. Involvement of protein kinases in the induction of NO synthase II in human DLD-1 cells. Br. J. Pharmacol. 1998, 123:1716-1722.
85. Kleinert H., Pautz A., Linker K., Schwarz P.M. Regulation of the expression of inducible nitric oxide synthase. Eur. J. Pharmacol. 2004, 500:255-266.
86. Kleinert H., Wallerath T., Fritz G., Ihrig-Biedert I., Rodriguez-Pascual F., Geller D.A., Forstermann U. Cytokine induction of NO synthase II in human DLD-1 cells: roles of the JAK-STAT, AP-1 and NF-kappaB-signaling pathways. Br. J. Pharmacol. 1998, 125:193-201.
87. Knowles R.G., Salter M., Brooks S.L., Moncada S. Anti-inflammatory glucocorticoids inhibit the induction by endotoxin of nitric oxide synthase in the lung, liver and aorta of the rat. Biochem. Biophys. Res. Commun. 1990, 172:1042-1048.
88. Kobayashi O., Miwa H., Watanabe S., Tsujii M., Dubois R.N., Sato N. Cyclooxygenase-2 downregulates inducible nitric oxide synthase in rat intestinal epithelial cells. Am. J. Physiol Gastrointest. Liver Physiol. 2001, 281:G688-G696.
89. Koide M., Kawahara Y., Nakayama I., Tsuda T., Yokoyama M. Cyclic AMP-elevating agents induce an inducible type of nitric oxide synthase in cultured vascular smooth muscle cells. Synergism with the induction elicited by inflammatory cytokines. J. Biol. Chem. 1993, 268:24959-24966.
90. Kolodziejski P.J., Koo J.S., Eissa N.T. Regulation of inducible nitric oxide synthase by rapid cellular turnover and cotranslational down-regulation by dimerization inhibitors. Proc. Natl Acad. Sci. U. S. A 2004, 101:18141-18146.
91. Korhonen R., Linker K., Pautz A., Forstermann U., Moilanen E., Kleinert H. Post-transcriptional regulation of human inducible nitric-oxide synthase expression by the Jun N-terminal kinase. Mol. Pharmacol. 2007, 71:1427-1434.
92. Korinek V., Barker N., Morin P.J., van W.D., de W.R., Kinzler K.W., Vogelstein B., Clevers H. Constitutive transcriptional activation by a beta-catenin-Tcf complex in APC-/- colon carcinoma. Science 1997, 275:1784-1787.
93. Kristof A.S., Fielhaber J., Triantafillopoulos A., Nemoto S., Moss J. Phosphatidylinositol 3-kinase-dependent suppression of the human inducible nitric-oxide synthase promoter is mediated by FKHRL1. J. Biol. Chem. 2006, 281:23958-23968.
94. Kristof A.S., Marks-Konczalik J., Moss J. Mitogen-activated protein kinases mediate activator protein-1-dependent human inducible nitric-oxide synthase promoter activation. J. Biol. Chem. 2001, 276:8445-8452.
95. Kunz D., Walker G., Eberhardt W., Nitsch D., Pfeilschifter J. Interleukin 1 beta-induced expression of nitric oxide synthase in rat renal mesangial cells is suppressed by cyclosporin A. Biochem. Biophys. Res. Commun. 1995, 216:438-446.
96. Kunz D., Walker G., Eberhardt W., Pfeilschifter J. Molecular mechanisms of dexamethasone inhibition of nitric oxide synthase expression in interleukin 1 beta-stimulated mesangial cells: evidence for the involvement of transcriptional and posttranscriptional regulation. Proc. Natl Acad. Sci. U. S. A 1996, 93:255-259.
97. Kunz D., Walker G., Pfeilschifter J. Dexamethasone differentially affects interleukin 1 beta- and cyclic AMP-induced nitric oxide synthase mRNA expression in renal mesangial cells. Biochem. J. 1994, 304(Pt 2):337-340.
98. Laskin D.L., Fakhrzadeh L., Heck D.E., Gerecke D., Laskin J.D. Upregulation of phosphoinositide 3-kinase and protein kinase B in alveolar macrophages following ozone inhalation. Role of NF-kappaB and STAT-1 in ozone-induced nitric oxide production and toxicity. Mol. Cell Biochem. 2002, 234-235:91-98.
99. Lee B.S., Kim Y.M., Kang H.S., Kim H.M., Pyun K.H., Choi I. Octamer binding protein-1 is involved in inhibition of inducible nitric oxide synthase expression by exogenous nitric oxide in murine liver cells. J. Biochem. 2001, 129:77-86.
100. Lee S.H., Nishino M., Mazumdar T., Garcia G.E., Galfione M., Lee F.L., Lee C.L., Liang A., Kim J., Feng L., Eissa N.T., Lin S.H., Yu-Lee L.Y. 16-kDa prolactin down-regulates inducible nitric oxide synthase expression through inhibition of the signal transducer and activator of transcription 1/IFN regulatory factor-1 pathway. Cancer Res. 2005, 65:7984-7992.
101. Li M., Pascual G., Glass C.K. Peroxisome proliferator-activated receptor gamma-dependent repression of the inducible nitric oxide synthase gene. Mol. Cell Biol. 2000, 20:4699-4707.
102. Linker K., Pautz A., Fechir M., Hubrich T., Greeve J., Kleinert H. Involvement of KSRP in the post-transcriptional regulation of human iNOS expression-complex interplay of KSRP with TTP and HuR. Nucleic Acids Res. 2005, 33:4813-4827.
103. Linn S.C., Morelli P.J., Edry I., Cottongim S.E., Szabo C., Salzman A.L. Transcriptional regulation of human inducible nitric oxide synthase gene in an intestinal epithelial cell line. Am. J. Physiol. 1997, 272:G1499-G1508.
104. Liu X., Miller C.W., Koeffler P.H., Berk A.J. The p53 activation domain binds the TATA box-binding polypeptide in Holo-TFIID, and a neighboring p53 domain inhibits transcription. Mol. Cell Biol. 1993, 13:3291-3300.
105. Liu Z.Z., Cui S., Billiar T.R., Dorko K., Halfter W., Geller D.A., Michalopoulos G., Beger H.G., Albina J., Nussler A.K. Effects of hepatocellular mitogens on cytokine-induced nitric oxide synthesis in human hepatocytes. J. Leukoc. Biol. 1996, 60:382-388.
106. Lo H.W., Hsu S.C., li-Seyed M., Gunduz M., Xia W., Wei Y., Bartholomeusz G., Shih J.Y., Hung M.C. Nuclear interaction of EGFR and STAT3 in the activation of the iNOS/NO pathway. Cancer Cell 2005, 7:575-589.
107. Lowenstein C.J., Alley E.W., Raval P., Snowman A.M., Snyder S.H., Russell S.W., Murphy W.J. Macrophage nitric oxide synthase gene: two upstream regions mediate induction by interferon gamma and lipopolysaccharide. Proc. Natl Acad. Sci. U. S. A 1993, 90:9730-9734.
108. Lowenstein C.J., Glatt C.S., Bredt D.S., Snyder S.H. Cloned and expressed macrophage nitric oxide synthase contrasts with the brain enzyme. Proc. Natl Acad. Sci. U. S. A 1992, 89:6711-6715.
109. Luss H., DiSilvio M., Litton A.L., Vedia L., Nussler A.K., Billiar T.R. Inhibition of nitric oxide synthesis enhances the expression of inducible nitric oxide synthase mRNA and protein in a model of chronic liver inflammation. Biochem. Biophys. Res. Commun. 1994, 204:635-640.
110. Luss H., Watkins S.C., Freeswick P.D., Imro A.K., Nussler A.K., Billiar T.R., Simmons R.L., del Nido P.J., McGowan F.X. Characterization of inducible nitric oxide synthase expression in endotoxemic rat cardiac myocytes in vivo and following cytokine exposure in vitro. J. Mol. Cell Cardiol. 1995, 27:2015-2029.
111. Marks-Konczalik J., Chu S.C., Moss J. Cytokine-mediated transcriptional induction of the human inducible nitric oxide synthase gene requires both activator protein 1 and nuclear factor kappaB-binding sites. J. Biol. Chem. 1998, 273:22201-22208.
112. Marsden P.A., Heng H.H., Scherer S.W., Stewart R.J., Hall A.V., Shi X.M., Tsui L.C., Schappert K.T. Structure and chromosomal localization of the human constitutive endothelial nitric oxide synthase gene. J. Biol. Chem. 1993, 268:17478-17488.
113. Martin E., Nathan C., Xie Q.W. Role of interferon regulatory factor 1 in induction of nitric oxide synthase. J. Exp. Med. 1994, 180:977-984.
114. Matouk C.C., Marsden P.A. Epigenetic regulation of vascular endothelial gene expression. Circ. Res. 2008, 102:873-887.
115. Matsui K., Nishizawa M., Ozaki T., Kimura T., Hashimoto I., Yamada M., Kaibori M., Kamiyama Y., Ito S., Okumura T. Natural antisense transcript stabilizes inducible nitric oxide synthase messenger RNA in rat hepatocytes. Hepatology 2008, 47:686-697.
116. Mellott J.K., Nick H.S., Waters M.F., Billiar T.R., Geller D.A., Chesrown S.E. Cytokine-induced changes in chromatin structure and in vivo footprints in the inducible NOS promoter. Am. J. Physiol Lung Cell Mol. Physiol. 2001, 280:L390-L399.
117. Mi Z., Guo H., Wai P.Y., Gao C., Wei J., Kuo P.C. Differential osteopontin expression in phenotypically distinct subclones of murine breast cancer cells mediates metastatic behavior. J. Biol. Chem. 2004, 279:46659-46667.
118. Miller L., Alley E.W., Murphy W.J., Russell S.W., Hunt J.S. Progesterone inhibits inducible nitric oxide synthase gene expression and nitric oxide production in murine macrophages. J. Leukoc. Biol. 1996, 59:442-450.
119. Misquitta C.M., Iyer V.R., Werstiuk E.S., Grover A.K. The role of 3'-untranslated region (3'-UTR) mediated mRNA stability in cardiovascular pathophysiology. Mol. Cell Biochem. 2001, 224:53-67.
120. Morin P.J. beta-catenin signaling and cancer. Bioessays 1999, 21:1021-1030.
121. Morris K.R., Lutz R.D., Choi H.S., Kamitani T., Chmura K., Chan E.D. Role of the NF-kappaB signaling pathway and kappaB cis-regulatory elements on the IRF-1 and iNOS promoter regions in mycobacterial lipoarabinomannan induction of nitric oxide. Infect. Immun. 2003, 71:1442-1452.
122. Muhl H., Kunz D., Rob P., Pfeilschifter J. Cyclosporin derivatives inhibit interleukin 1 beta induction of nitric oxide synthase in renal mesangial cells. Eur. J. Pharmacol. 1993, 249:95-100.
123. Mullet D., Fertel R.H., Kniss D., Cox G.W. An increase in intracellular cyclic AMP modulates nitric oxide production in IFN-gamma-treated macrophages. J. Immunol. 1997, 158:897-904.
124. Mustafa S.B., Olson M.S. Expression of nitric-oxide synthase in rat Kupffer cells is regulated by cAMP. J. Biol. Chem. 1998, 273:5073-5080.
125. Nathan C., Xie Q.W. Nitric oxide synthases: roles, tolls, and controls. Cell 1994, 78:915-918.
126. Navarro-Lerida I., Corvi M.M., Barrientos A.A., Gavilanes F., Berthiaume L.G., Rodriguez-Crespo I. Palmitoylation of inducible nitric-oxide synthase at Cys-3 is required for proper intracellular traffic and nitric oxide synthesis. J. Biol. Chem. 2004, 279:55682-55689.
127. Nunokawa Y., Oikawa S., Tanaka S. Human inducible nitric oxide synthase gene is transcriptionally regulated by nuclear factor-kappaB dependent mechanism. Biochem. Biophys. Res. Commun. 1996, 223:347-352.
128. Nunokawa Y., Oikawa S., Tanaka S. Expression of human inducible nitric oxide synthase is regulated by both promoter and 3'-regions. Biochem. Biophys. Res. Commun. 1997, 233:523-526.
129. Nusse R. Wnt signaling in disease and in development. Cell Res. 2005, 15:28-32.
130. Nussler A.K., Di Silvio M., Billiar T.R., Hoffman R.A., Geller D.A., Selby R., Madariaga J., Simmons R.L. Stimulation of the nitric oxide synthase pathway in human hepatocytes by cytokines and endotoxin. J. Exp. Med. 1992, 176:261-264.
131. Nussler A.K., Di Silvio M., Liu Z.Z., Geller D.A., Freeswick P., Dorko K., Bartoli F., Billiar T.R. Further characterization and comparison of inducible nitric oxide synthase in mouse, rat, and human hepatocytes. Hepatology 1995, 21:1552-1560.
132. Ochoa J.B., Curti B., Peitzman A.B., Simmons R.L., Billiar T.R., Hoffman R., Rault R., Longo D.L., Urba W.J., Ochoa A.C. Increased circulating nitrogen oxides after human tumor immunotherapy: correlation with toxic hemodynamic changes. J. Natl Cancer Inst. 1992, 84:864-867.
133. Oh J.W., Lee J.Y., Han S.H., Moon Y.H., Kim Y.G., Woo E.R., Kang K.W. Effects of phenylethanoid glycosides from Digitalis purpurea L. on the expression of inducible nitric oxide synthase. J. Pharm. Pharmacol. 2005, 57:903-910.
134. Pahan K., Jana M., Liu X., Taylor B.S., Wood C., Fischer S.M. Gemfibrozil, a lipid-lowering drug, inhibits the induction of nitric-oxide synthase in human astrocytes J. Biol. Chem. 2002, 277:45984-45991.
135. Pahan K., Liu X., McKinney M.J., Wood C., Sheikh F.G., Raymond J.R. Expression of a dominant-negative mutant of p21(ras) inhibits induction of nitric oxide synthase and activation of nuclear factor-kappaB in primary astrocytes. J. Neurochem. 2000, 74:2288-2295.
136. Paludan S.R., Malmgaard L., Ellermann-Eriksen S., Bosca L., Mogensen S.C. Interferon (IFN)-gamma and Herpes simplex virus/tumor necrosis factor-alpha synergistically induce nitric oxide synthase 2 in macrophages through cooperative action of nuclear factor-kappa B and IFN regulatory factor-1. Eur. Cytokine Netw. 2001, 12:297-308.
137. Pance A., Chantome A., Reveneau S., Bentrari F., Jeannin J.F. A repressor in the proximal human inducible nitric oxide synthase promoter modulates transcriptional activation. FASEB J. 2002, 16:631-633.
138. Park S.K., Lin H.L., Murphy S. Nitric oxide regulates nitric oxide synthase-2 gene expression by inhibiting NF-kappaB binding to DNA. Biochem. J. 1997, 322(Pt 2):609-613.
139. Parry G.C., Mackman N. Role of cyclic AMP response element-binding protein in cyclic AMP inhibition of NF-kappaB-mediated transcription. J. Immunol. 1997, 159:5450-5456.
140. Paukkeri E.L., Leppanen T., Sareila O., Vuolteenaho K., Kankaanranta H., Moilanen E. PPARalpha agonists inhibit nitric oxide production by enhancing iNOS degradation in LPS-treated macrophages. Br. J. Pharmacol. 2007, 152:1081-1091.
141. Pautz A., Linker K., Hubrich T., Korhonen R., Altenhofer S., Kleinert H. The polypyrimidine tract-binding protein (PTB) is involved in the post-transcriptional regulation of human inducible nitric oxide synthase expression. J. Biol. Chem. 2006, 281:32294-32302.
142. Pautz A., Linker K., Altenhöfer S., Heil S., Schmidt N., Art J. Similar regulation of human inducible nitric-oxide synthase expression by different isoforms of the RNA-binding protein AUF1. J. Biol. Chem.
143. Perrella M.A., Patterson C., Tan L., Yet S.F., Hsieh C.M., Yoshizumi M., Lee M.E. Suppression of interleukin-1beta-induced nitric-oxide synthase promoter/enhancer activity by transforming growth factor-beta1 in vascular smooth muscle cells. Evidence for mechanisms other than NF-kappaB. J. Biol. Chem. 1996, 271:13776-13780.
144. Perrella M.A., Yoshizumi M., Fen Z., Tsai J.C., Hsieh C.M., Kourembanas S., Lee M.E. Transforming growth factor-beta 1, but not dexamethasone, down-regulates nitric-oxide synthase mRNA after its induction by interleukin-1 beta in rat smooth muscle cells. J. Biol. Chem. 1994, 269:14595-14600.
145. Pfeilschifter J., Vosbeck K. Transforming growth factor beta 2 inhibits interleukin 1 beta- and tumour necrosis factor alpha-induction of nitric oxide synthase in rat renal mesangial cells. Biochem. Biophys. Res. Commun. 1991, 175:372-379.
146. Radomski M.W., Palmer R.M., Moncada S. Glucocorticoids inhibit the expression of an inducible, but not the constitutive, nitric oxide synthase in vascular endothelial cells. Proc. Natl Acad. Sci. U. S. A 1990, 87:10043-10047.
147. Rak M.K., Lee H., Hak K.B., Chung E., Min C.S., Kim Y. Inhibitory effect of 6-hydroxy-7-methoxychroman-2-carboxylic acid phenylamide on nitric oxide and interleukin-6 production in macrophages. Life Sci. 2005, 77:3242-3257.
148. Rao C.V., Reddy B.S., Steele V.E., Wang C.X., Liu X., Ouyang N., Patlolla J.M., Simi B., Kopelovich L., Rigas B. Nitric oxide-releasing aspirin and indomethacin are potent inhibitors against colon cancer in azoxymethane-treated rats: effects on molecular targets. Mol. Cancer Ther. 2006, 5:1530-1538.
149. Rattan R., Giri S., Singh A.K., Singh I. Rho A negatively regulates cytokine-mediated inducible nitric oxide synthase expression in brain-derived transformed cell lines: negative regulation of IKKalpha. Free Radic. Biol. Med. 2003, 35:1037-1050.
150. Ravi R., Mookerjee B., van H.Y., Bedi G.C., Giordano A., El-Deiry W.S., Fuchs E.J., Bedi A. p53-mediated repression of nuclear factor-kappaB RelA via the transcriptional integrator p300. Cancer Res. 1998, 58:4531-4536.
151. Ricote M., Li A.C., Willson T.M., Kelly C.J., Glass C.K. The peroxisome proliferator-activated receptor-gamma is a negative regulator of macrophage activation. Nature 1998, 391:79-82.
152. Roberts A.B., Vodovotz Y., Roche N.S., Sporn M.B., Nathan C.F. Role of nitric oxide in antagonistic effects of transforming growth factor-beta and interleukin-1 beta on the beating rate of cultured cardiac myocytes. Mol. Endocrinol. 1992, 6:1921-1930.
153. Rodriguez-Pascual F., Hausding M., Ihrig-Biedert I., Furneaux H., Levy A.P., Forstermann U., Kleinert H. Complex contribution of the 3'-untranslated region to the expressional regulation of the human inducible nitric-oxide synthase gene. Involvement of the RNA-binding protein HuR. J. Biol. Chem. 2000, 275:26040-26049.
154. Ryan A.K., Rosenfeld M.G. POU domain family values: flexibility, partnerships, and developmental codes. Genes Dev 1997, 11:1207-1225.
155. Saha R.N., Jana M., Pahan K. MAPK p38 regulates transcriptional activity of NF-kappaB in primary human astrocytes via acetylation of p65. J. Immunol. 2007, 179:7101-7109.
156. Salzman A., Denenberg A.G., Ueta I., O'Connor M., Linn S.C., Szabo C. Induction and activity of nitric oxide synthase in cultured human intestinal epithelial monolayers. Am. J. Physiol. 1996, 270:G565-G573.
157. Samardzic T., Jankovic V., Stosic-Grujicic S., Trajkovic V. STAT1 is required for iNOS activation, but not IL-6 production in murine fibroblasts. Cytokine 2001, 13:179-182.
158. Sanchez A.C., Davis R.L., Syapin P.J. The Oct DNA motif participates in the alcohol inhibition of the inducible nitric oxide synthase gene promoter in rat C6 glioma cells. Brain Res. 2007, 1179:16-27.
159. Saura M., Martinez-Dalmau R., Minty A., Perez-Sala D., Lamas S. Interleukin-13 inhibits inducible nitric oxide synthase expression in human mesangial cells. Biochem. J. 1996, 313(Pt 2):641-646.
160. Sawada T., Falk L.A., Rao P., Murphy W.J., Pluznik D.H. IL-6 induction of protein-DNA complexes via a novel regulatory region of the inducible nitric oxide synthase gene promoter: role of octamer binding proteins. J. Immunol. 1997, 158:5267-5276.
161. Scott-Burden T., Elizondo E., Ge T., Boulanger C.M., Vanhoutte P.M. Simultaneous activation of adenylyl cyclase and protein kinase C induces production of nitric oxide by vascular smooth muscle cells. Mol. Pharmacol. 1994, 46:274-282.
162. Shao L., Guo Z., Geller D.A. Transcriptional suppression of cytokine-induced iNOS gene expression by IL-13 through IRF-1/ISRE signaling. Biochem. Biophys. Res. Commun. 2007, 362:582-586.
163. Shaw G., Kamen R. A conserved AU sequence from the 3' untranslated region of GM-CSF mRNA mediates selective mRNA degradation. Cell 1986, 46:659-667.
164. Sherman P.A., Laubach V.E., Reep B.R., Wood E.R. Purification and cDNA sequence of an inducible nitric oxide synthase from a human tumor cell line. Biochemistry 1993, 32:11600-11605.
165. Smyth T., Harris H.J., Brown A., Totemeyer S., Farnfield B.A., Maskell D.J., Matsumoto M., Plevin R., Alldridge L.C., Bryant C.E. Differential modulatory effects of annexin 1 on nitric oxide synthase induction by lipopolysaccharide in macrophages. Immunology 2006, 117:340-349.
166. Soares M.P., Muniappan A., Kaczmarek E., Koziak K., Wrighton C.J., Steinhauslin F., Ferran C., Winkler H., Bach F.H., Anrather J. Adenovirus-mediated expression of a dominant negative mutant of p65/RelA inhibits proinflammatory gene expression in endothelial cells without sensitizing to apoptosis. J. Immunol. 1998, 161:4572-4582.
167. Soderberg M., Raffalli-Mathieu F., Lang M.A. Identification of a regulatory cis-element within the 3'-untranslated region of the murine inducible nitric oxide synthase (iNOS) mRNA; interaction with heterogeneous nuclear ribonucleoproteins I and L and role in the iNOS gene expression. Mol. Immunol. 2007, 44:434-442.
168. Spink J., Cohen J., Evans T.J. The cytokine responsive vascular smooth muscle cell enhancer of inducible nitric oxide synthase. Activation by nuclear factor-kappa B. J. Biol. Chem. 1995, 270:29541-29547.
169. Spitzer J.A., Zheng M., Kolls J.K., Vande S.C., Spitzer J.J. Ethanol and LPS modulate NF-kappaB activation, inducible NO synthase and COX-2 gene expression in rat liver cells in vivo. Front. Biosci. 2002, 7:a99-a108.
170. Stuehr D.J., Marletta M.A. Mammalian nitrate biosynthesis: mouse macrophages produce nitrite and nitrate in response to Escherichia coli lipopolysaccharide. Proc. Natl Acad. Sci. U. S. A 1985, 82:7738-7742.
171. Sturm R.A., Herr W. The POU domain is a bipartite DNA-binding structure. Nature 1988, 336:601-604.
172. Takaki H., Minoda Y., Koga K., Takaesu G., Yoshimura A., Kobayashi T. TGF-beta1 suppresses IFN-gamma-induced NO production in macrophages by suppressing STAT1 activation and accelerating iNOS protein degradation. Genes Cells 2006, 11:871-882.
173. Taylor B.S., de Vera M.E., Ganster R.W., Wang Q., Shapiro R.A., Morris S.M., Billiar T.R., Geller D.A. Multiple NF-kappaB enhancer elements regulate cytokine induction of the human inducible nitric oxide synthase gene. J. Biol. Chem. 1998, 273:15148-15156.
174. Taylor B.S., Geller D.A. Molecular regulation of the human inducible nitric oxide synthase (iNOS) gene. Shock 2000, 13:413-424.
175. Taylor B.S., Kim Y.M., Wang Q., Shapiro R.A., Billiar T.R., Geller D.A. Nitric oxide down-regulates hepatocyte-inducible nitric oxide synthase gene expression. Arch. Surg. 1997, 132:1177-1183.
176. Teng X., Li D., Catravas J.D., Johns R.A. C/EBP-beta mediates iNOS induction by hypoxia in rat pulmonary microvascular smooth muscle cells. Circ. Res. 2002, 90:125-127.
177. Teng X., Zhang H., Snead C., Catravas J.D. Molecular mechanisms of iNOS induction by IL-1 beta and IFN-gamma in rat aortic smooth muscle cells. Am. J. Physiol. Cell Physiol. 2002, 282:C144-C152.
178. Trajkovic V., Stosic-Grujicic S., Samardzic T., Markovic M., Miljkovic D., Ramic Z., Mostarica S.M. Interleukin-17 stimulates inducible nitric oxide synthase activation in rodent astrocytes. J. Neuroimmunol. 2001, 119:183-191.
179. Trepicchio W.L., Wang L., Bozza M., Dorner A.J. IL-11 regulates macrophage effector function through the inhibition of nuclear factor-kappa B. J. Immunol. 1997, 159:5661-5670.
180. Vallance P., Collier J., Moncada S. Effects of endothelium-derived nitric oxide on peripheral arteriolar tone in man. Lancet 1989, 2:997-1000.
181. Verrijzer C.P., Van der Vliet P.C. POU domain transcription factors. Biochim. Biophys. Acta. 1993, 1173:1-21.
182. Vila-del S., Vaz-Munoz M.D., Fresno M. Requirement of tumor necrosis factor alpha and nuclear factor-kappaB in the induction by IFN-gamma of inducible nitric oxide synthase in macrophages. J. Leukoc. Biol. 2007, 81:272-283.
183. Vodovotz Y., Bogdan C., Paik J., Xie Q.W., Nathan C. Mechanisms of suppression of macrophage nitric oxide release by transforming growth factor beta. J. Exp. Med. 1993, 178:605-613.
184. Wakabayashi I., Negoro M. Mechanism of inhibitory action of ethanol on inducible nitric oxide synthesis in macrophages. Naunyn Schmiedebergs Arch. Pharmacol. 2002, 366:299-306.
185. Wang B., Ma L., Tao X., Lipsky P.E. Triptolide, an active component of the Chinese herbal remedy Tripterygium wilfordii Hook F, inhibits production of nitric oxide by decreasing inducible nitric oxide synthase gene transcription. Arthritis Rheum. 2004, 50:2303-2995.
186. Weber T.J., Smallwood H.S., Kathmann L.E., Markillie L.M., Squier T.C., Thrall B.D. Functional link between TNF biosynthesis and CaM-dependent activation of inducible nitric oxide synthase in RAW 264.7 macrophages. Am. J. Physiol. Cell Physiol. 2006, 290:C1512-C1520.
187. Witteck A., Yao Y., Fechir M., Forstermann U., Kleinert H. Rho protein-mediated changes in the structure of the actin cytoskeleton regulate human inducible NO synthase gene expression. Exp. Cell Res. 2003, 287:106-115.
188. Won J.S., Im Y.B., Singh A.K., Singh I. Dual role of cAMP in iNOS expression in glial cells and macrophages is mediated by differential regulation of p38-MAPK/ATF-2 activation and iNOS stability. Free Radic. Biol. Med. 2004, 37:1834-1844.
189. Wu F., Tyml K., Wilson J.X. iNOS expression requires NADPH oxidase-dependent redox signaling in microvascular endothelial cells. J. Cell Physiol. 2008, 217:207-214.
190. Xie Q. A novel lipopolysaccharide-response element contributes to induction of nitric oxide synthase. J. Biol. Chem. 1997, 272:14867-14872.
191. Xie Q.W., Cho H.J., Calaycay J., Mumford R.A., Swiderek K.M., Lee T.D., Ding A., Troso T., Nathan C. Cloning and characterization of inducible nitric oxide synthase from mouse macrophages. Science 1992, 256:225-228.
192. Xie Q.W., Whisnant R., Nathan C. Promoter of the mouse gene encoding calcium-independent nitric oxide synthase confers inducibility by interferon gamma and bacterial lipopolysaccharide. J. Exp. Med. 1993, 177:1779-1784.
193. Xiong H., Zhu C., Li H., Chen F., Mayer L., Ozato K., Unkeless J.C., Plevy S.E. Complex formation of the interferon (IFN) consensus sequence-binding protein with IRF-1 is essential for murine macrophage IFN-gamma-induced iNOS gene expression. J. Biol. Chem. 2003, 278:2271-2277.
194. Yang J.W., Pokharel Y.R., Kim M.R., Woo E.R., Choi H.K., Kang K.W. Inhibition of inducible nitric oxide synthase by sumaflavone isolated from Selaginella tamariscina. J. Ethnopharmacol. 2006, 105:107-113.
195. Yasuda T., Kanno M., Kawamoto M., Yuge O., Ninomiya Y. Suppression of inducible nitric oxide synthase and cyclooxygenase-2 gene expression by 22(R)-hydroxycholesterol requires de novo protein synthesis in activated macrophages. J. Steroid Biochem. Mol. Biol. 2005, 97:376-383.
196. Yu Z., Kone B.C. Hypermethylation of the inducible nitric-oxide synthase gene promoter inhibits its transcription. J. Biol. Chem. 2004, 279:46954-46961.
197. Yu Z., Zhang W., Kone B.C. Signal transducers and activators of transcription 3 (STAT3) inhibits transcription of the inducible nitric oxide synthase gene by interacting with nuclear factor kappaB. Biochem. J. 2002, 367:97-105.
198. Zhang X., Laubach V.E., Alley E.W., Edwards K.A., Sherman P.A., Russell S.W., Murphy W.J. Transcriptional basis for hyporesponsiveness of the human inducible nitric oxide synthase gene to lipopolysaccharide/interferon-gamma. J. Leukoc. Biol. 1996, 59:575-585.
199. Zhang Y.H., Murphy W.J., Russell S.W., Morrison D.C., Koide N., Yoshida T., Yokochi T. Serum-dependent potentiation of lipopolysaccharide-induced nitric oxide production is mediated by the events after the transcription of inducible type of nitric oxide synthase. Cell Immunol. 2005, 234:16-22.
200. Ziesche E., Bachmann M., Kleinert H., Pfeilschifter J., Muhl H. The interleukin-22/STAT3 pathway potentiates expression of inducible nitric-oxide synthase in human colon carcinoma cells. J. Biol. Chem. 2007, 282:16006-16015.